- Home
- AVIR vs PMO Comparison
AVIR vs PMO Comparison
Compare AVIR & PMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- PMO
- Stock Information
- Founded
- AVIR 2012
- PMO 1993
- Country
- AVIR United States
- PMO United States
- Employees
- AVIR N/A
- PMO N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- PMO Finance Companies
- Sector
- AVIR Health Care
- PMO Finance
- Exchange
- AVIR Nasdaq
- PMO Nasdaq
- Market Cap
- AVIR 273.7M
- PMO 308.4M
- IPO Year
- AVIR 2020
- PMO N/A
- Fundamental
- Price
- AVIR $2.85
- PMO $10.22
- Analyst Decision
- AVIR Hold
- PMO
- Analyst Count
- AVIR 1
- PMO 0
- Target Price
- AVIR $6.88
- PMO N/A
- AVG Volume (30 Days)
- AVIR 247.5K
- PMO 99.0K
- Earning Date
- AVIR 03-06-2025
- PMO 01-01-0001
- Dividend Yield
- AVIR N/A
- PMO 4.10%
- EPS Growth
- AVIR N/A
- PMO N/A
- EPS
- AVIR N/A
- PMO 0.42
- Revenue
- AVIR N/A
- PMO N/A
- Revenue This Year
- AVIR N/A
- PMO N/A
- Revenue Next Year
- AVIR N/A
- PMO N/A
- P/E Ratio
- AVIR N/A
- PMO $24.38
- Revenue Growth
- AVIR N/A
- PMO N/A
- 52 Week Low
- AVIR $2.75
- PMO $8.57
- 52 Week High
- AVIR $4.15
- PMO $10.68
- Technical
- Relative Strength Index (RSI)
- AVIR 36.06
- PMO 39.12
- Support Level
- AVIR $2.90
- PMO $10.10
- Resistance Level
- AVIR $3.29
- PMO $10.43
- Average True Range (ATR)
- AVIR 0.12
- PMO 0.10
- MACD
- AVIR -0.03
- PMO -0.01
- Stochastic Oscillator
- AVIR 8.33
- PMO 36.36
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About PMO Putnam Municipal Opportunities Trust
Putnam Municipal Opportunities Trust is a non-diversified closed-end management investment company. It seeks to provide as high a level of current income free from federal income tax as Putnam Management believes is consistent with the preservation of capital. The fund invests in healthcare, utilities, transportation, tax bonds, local debt, state debt, and education.